Pictet Asset Management (UK)’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Pictet Asset Management (UK)’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-440,467	Closed	-$3.95M	–	887
2016 Q3	$3.95M	Buy	440,467 +27,400	+7%	+$195K	0.01%	626
2016 Q2	$2.28M	Buy	413,067 +175,667	+74%	+$901K	0.01%	732
2016 Q1	$821K	Hold	237,400	–	–	﹤0.01%	762
2015 Q4	$1.24M	Sell	237,400 -115,600	-33%	-$671K	0.01%	770
2015 Q3	$2.14M	Buy	353,000 +14,300	+4%	+$175K	0.01%	718
2015 Q2	$4.82M	Buy	+338,700	New	+$4.11M	0.02%	597
2015 Q1	–	Sell	-356,500	Closed	-$3.75M	–	915
2014 Q4	$3.75M	Buy	356,500 +3,000	+0.8%	+$29.3K	0.02%	647
2014 Q3	$3.39M	Buy	+353,500	New	+$3.61M	0.02%	643

Pictet Asset Management (UK)'s RPTP Position: Q4 2016 in Review

Pictet Asset Management (UK) sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 440,467 shares — an estimated $3.95M sold.

Pictet Asset Management (UK) first reported a position in RPTP in Q3 2014 and held it in 8 quarters. The position peaked at $4.82M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Pictet Asset Management (UK) reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Pictet Asset Management (UK) sold 440,467 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $3.95M.
Pictet Asset Management (UK) first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 8 quarters.
Pictet Asset Management (UK)'s RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $4.82M in Q2 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2016, filed 13 Feb 2017.